Potential Regulatory Consequences of the U.S. Nuclear Regulatory Commission Designation of Food and Drug Administration Approved Intravascular Brachytherapy Systems as High Dose Rate Remote Afterloading Devices
Byline
Glenn P. Glasgow*, Loyola University Chicago, Maywood, IL, US
